The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
from NDTV News - Topstories https://ift.tt/2EntxSq
Subscribe to:
Post Comments (Atom)
Insurance Bill to boost FDI, give regulator more power
from Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/09bFKtB
-
China has emerged as a significant player in AI foundation models with DeepSeek, creating powerful AI models at lower costs than the West. T...
-
Collecting Lego — yes, the plastic toys made of interlocking bricks that become cars and castles and robots —returned more than large stocks...
-
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News http://bit.ly/2VEK8DU...
No comments:
Post a Comment